{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:59:16Z","timestamp":1792144756243,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.schres.2022.09.021","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T08:09:52Z","timestamp":1663229392000},"page":"275-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Clozapine as a treatment for catatonia: A systematic review"],"prefix":"10.1016","volume":"263","author":[{"given":"Aman","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazifa","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Matti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dory Anthony","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Fripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyn","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.09.021_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","year":"2013"},{"key":"10.1016\/j.schres.2022.09.021_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-9338(12)75399-3","article-title":"P-1232 - hyperthermic catatonia and electroconvulsive therapy: analysis of a successful case","author":"Bairrada","year":"2012","journal-title":"Eur.Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/0010-440X(77)90040-2","article-title":"Results and side effects of treatment with clozapine (leponex R)","author":"Battegay","year":"1977","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2017.06.011","article-title":"Alternative treatment strategies for catatonia: a systematic review","author":"Beach","year":"2017","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/01.pra.0000336753.11943.7c","article-title":"Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review","author":"Bitter","year":"2008","journal-title":"J. Psychiatr. Pract."},{"issue":"3","key":"10.1016\/j.schres.2022.09.021_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.psychres.2006.09.006","article-title":"Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?","volume":"158","author":"Bonnot","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2022.09.021_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2009.08.018","article-title":"Treatment of catatonia with olanzapine: a case report","author":"Chang","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0b013e31824b1b0c","article-title":"Catatonia and encephalopathy associated with paliperidone palmitate","author":"Coffey","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2022.09.021_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.23.2.jnp223","article-title":"Catatonia in psychotic patients: clinical features and treatment response","volume":"23","author":"England","year":"2011","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2022.09.021_bb0050","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v58n1206a","article-title":"Clozapine-benzodiazepine interactions [1]","author":"Faisal","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/YCT.0b013e3181616c26","article-title":"The effect of electroconvulsive therapy on autobiographical memory: a systematic review","author":"Fraser","year":"2008","journal-title":"J.ECT"},{"key":"10.1016\/j.schres.2022.09.021_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/PSY.0000000000000574","article-title":"Catatonic stupor in schizophrenic disorders and subsequent medical complications and mortality","author":"Funayama","year":"2018","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.schres.2022.09.021_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2003.11.011","article-title":"Clozapine maintenance therapy in schizophrenia","author":"Gaszner","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.1977.01770200085010","article-title":"Catatonic reactions to high-potency neuroleptic drugs","author":"Gelenberg","year":"1977","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-020-00889-y","article-title":"GABAB receptor, clozapine, and catatonia\u2014a complex triad","author":"Hirjak","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0085","doi-asserted-by":"crossref","DOI":"10.1345\/aph.18286","article-title":"Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature","author":"Karagianis","year":"1999","journal-title":"Ann. Pharmacother."},{"issue":"12","key":"10.1016\/j.schres.2022.09.021_bb0090","first-page":"2155","article-title":"Neuroleptic malignant syndrome: a review and report of six cases","volume":"89","author":"Kasantikul","year":"2006","journal-title":"J. Med. Assoc. Thail."},{"key":"10.1016\/j.schres.2022.09.021_bb0095","doi-asserted-by":"crossref","DOI":"10.1080\/00207450902984002","article-title":"Rotarod impairment: catalepsy-like screening test for antipsychotic side effects","author":"Kirschbaum","year":"2009","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.schres.2022.09.021_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-018-0192-9","article-title":"Review of withdrawal catatonia: what does this reveal about clozapine?","author":"Lander","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0105","doi-asserted-by":"crossref","DOI":"10.3109\/10401239709147792","article-title":"Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report","author":"Lee","year":"1997","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2016.01.011","article-title":"Relapses and recurrences of catatonia: 30-case analysis and literature review","author":"Lin","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","author":"Murad","year":"2018","journal-title":"Evid.-Based Med."},{"key":"10.1016\/j.schres.2022.09.021_bb0120","series-title":"Clozapine and Neuroleptic Malignant Syndrome","author":"Mylan","year":"2018"},{"key":"10.1016\/j.schres.2022.09.021_bb0125","doi-asserted-by":"crossref","DOI":"10.1192\/S0007125000296931","article-title":"Clinical management of clozapine patients in relation to efficacy and side-effects","author":"Naber","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-020-0709-5","article-title":"Binding of clozapine to the GABAB receptor: clinical and structural insights","author":"Nair","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0135","series-title":"Guidance on the Use of Electroconvulsive Therapy","author":"NICE","year":"2003"},{"key":"10.1016\/j.schres.2022.09.021_bb0140","series-title":"Overview | Psychosis and Schizophrenia in Adults: Prevention and Management | Guidance | NICE","author":"NICE","year":"2014"},{"key":"10.1016\/j.schres.2022.09.021_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-017-0552-9","article-title":"Clozapine as a model for antipsychotic development","author":"Nucifora","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.schres.2022.09.021_bb0150","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2022.09.021_bb0155","doi-asserted-by":"crossref","DOI":"10.2147\/NDT.S147897","article-title":"Systematic review of catatonia treatment","author":"Pelzer","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2022.09.021_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/s00787-014-0595-y","article-title":"Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia","author":"Raffin","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0165","doi-asserted-by":"crossref","DOI":"10.1176\/jnp.10.2.237","article-title":"Organic catatonia following frontal lobe injury: response to clozapine [3]","author":"Rommel","year":"1998","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2022.09.021_bb0170","series-title":"Foot & Ankle Surgery: Techniques, Reports & Cases","article-title":"Case reports\/series & bias considerations","author":"Roukis","year":"2021"},{"key":"10.1016\/j.schres.2022.09.021_bb0175","author":"Saini"},{"key":"10.1016\/j.schres.2022.09.021_bb0180","article-title":"Excited delirium: consideration of selected medical and psychiatric issues","author":"Samuel","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2022.09.021_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/284472a0","article-title":"Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors","author":"Sanberg","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.schres.2022.09.021_bb0190","doi-asserted-by":"crossref","DOI":"10.2165\/00003088-200342070-00001","article-title":"What is an adequate trial with clozapine?","author":"Schulte","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.schres.2022.09.021_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A clinical review of the treatment of catatonia","author":"Sienaert","year":"2014","journal-title":"Front.Psychiatry"},{"key":"10.1016\/j.schres.2022.09.021_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbx157","article-title":"Prevalence of catatonia and its moderators in clinical samples: results from a meta-analysis and meta-regression analysis","author":"Solmi","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.09.021_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.chc.2018.07.005","article-title":"Anti-N-methyl D-aspartate receptor encephalitis and electroconvulsive therapy: literature review and future directions","author":"Tanguturi","year":"2019","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.schres.2022.09.021_bb0210","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","first-page":"849","article-title":"The Maudsley prescribing guidelines in psychiatry","author":"Taylor","year":"2021"},{"key":"10.1016\/j.schres.2022.09.021_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/00131746-200701000-00003","article-title":"EPS profiles: the atypical antipsychotics - are not all the same","author":"Weiden","year":"2007","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.schres.2022.09.021_bb0220","doi-asserted-by":"crossref","DOI":"10.1515\/IJAMH.2004.16.2.179","article-title":"Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents","author":"Zalsman","year":"2004","journal-title":"Int.J.Adolesc.Med.Health"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422003632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422003632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:55:51Z","timestamp":1760298951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422003632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"alternative-id":["S0920996422003632"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.09.021","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine as a treatment for catatonia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}